Lundbeck

VYEPTI

Manufacturer:

Lundbeck

Vyepti HCPCS:

J3032

HCPCS Code Descriptor:

Injection, eptinezumab-jjmr, 1 mg

Category:

J Code

Vyepti NDCs:

67386-0130-51

Primary Type:

Neurology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Vyepti:

VYEPTI is a Neurology drug manufactured by Lundbeck and administered via the Intravenous route of administration. The J Code: J3032 is aligned to the drug VYEPTI.

ACCESS PRICING AND MORE BY REGISTERING

J3032 Added Date:

October 1, 2020

J3032 Effective Date:

October 1, 2020

J3032 Termination Date:

HCPCS Active

Vyepti billing and coding information can be found through Lundbeck at the link below:
Vyepti patient assistance information can be found through Lundbeck Patient Assistance at the URL: https://www.lundbeck.com/us/about-us/lundbeck-in-the-us/patient-assistance
VYEPTI prescribing information can be found at the link below:
Information regarding VYEPTI’s side effects can be found at MedlinePlus